RECHERCHE ET INNOVATIONS
« Une discipline médicale qui ne fait pas de recherche est une discipline appelée à disparaître ».
Une recherche clinique médicale et paramédicale active
Le centre hospitalier de Rouffach via l’activité de recherche en neurosciences du pôle 8/9 s’est inscrit depuis de nombreuses années dans une dynamique dont les résultats sont régulièrement publiés dans des revues internationales de psychiatrie à fort facteur d’impact.
S’appuyant cette recherche, cela a permis :
- Une rationalisation de la démarche de soins,
- L’élaboration de procédures et de protocoles thérapeutiques pour une évaluation de la pertinence des pratiques professionnelles,
- Une démarche de recherche interventionnelle via la participation à différents types d’essais cliniques portant sur des produits de santé,
- Une démarche de recherche paramédicale permettant de développer de nouvelles thérapies individuelles et de groupe.
Dans le cadre de cette recherche, le centre hospitalier de Rouffach entretient des relations avec les instituts de recherche strasbourgeois :
Il a conclu un partenariat avec la délégation à la recherche clinique du GHRMSA par la signature d’une convention lui permettant de valoriser sa recherche tout en bénéficiant des connaissances techniques de cette équipe expérimentée.
Enfin, le centre hospitalier de Rouffach est membre du réseau Fondamental.
Des collaborations fortes avec le CCOMS de Lille.
Le centre hospitalier est engagé comme partenaire du Centre collaborateur de l’OMS (CCOMS) dans des projets de recherche en santé mentale. Il est partie prenante dans :
- La recherche Tabapsy, dont l’objectif est la diminution du taux de tabagisme chez les personnes suivies en psychiatrie,
- Le programme Quality Right qui cherche à améliorer la qualité des soins et le respect des droits des usagers dans les services de santé mentale,
- Les enquêtes SMPG (santé mentale en population générale) pour mieux connaître les besoins et les représentations en santé mentale d’un territoire,
- L’étude « Santé et qualité de vie au travail » pour mesurer les risques psycho-sociaux en psychiatrie.
Les publications du centre hospitalier de Rouffach
Retrouvez dans cette section l’ensemble des publications du centre hospitalier de Rouffach, depuis 2004 jusqu’en 2023. Tout l’historique est accessible depuis la liste déroulante ci-après. Il vous suffit de sélectionner l’année en question pour voir apparaître les résultats.
| Duval, F. (2023). Systematic Review of the Apomorphine Challenge Test in the Assessment of Dopaminergic Activity in Schizophrenia. Healthcare, 11(10), 1487. https://doi.org/10.3390/healthcare11101487 |
| Duval, F., Mokrani, M.-C., Danila, V., Lopera, F. G., Erb, A., & Tomsa, M. (2023). Hypothalamic-prolactin axis regulation in major depressed patients with suicidal behavior. Psychoneuroendocrinology, 151, 106050. https://doi.org/10.1016/j.psyneuen.2023.106050 |
| Duval F, Mokrani MC, Danila V, Erb A, Gonzalez Lopera F, Tomsa M. Dopamine Function and Hypothalamic-Pituitary-Thyroid Axis Activity in Major Depressed Patients with Suicidal Behavior. Brain Sci.2022,12,621. https://doi.org/10.3390/brainsci12050621 |
| Duval F, Mokrani MC, Danila V, Erb A, Gonzalez Lopera F, Tomsa M. Effect of repetitive transcranial magnetic stimulation on chronobiological hypothalamic-pituitary-thyroid axis activity in major depression. Biol Psychiatry 2022;91:S205 |
| Duval F, Mokrani MC, Danila V, Erb A, Gonzalez Lopera F, Tomsa M. Thyroid Axis Activity and Dopamine Function in Major Depressed Patients with Suicidal Behavior. Biol Psychiatry 2022;91:S376 |
| Les échelles anticholinergiques : usage en psychiatrie et mise à jour de l’échelle d’imprégnation anticholinergique. JAVELOT H, MEYER G, BECKER G, POST G, POSPIESZYNSKI P, COLLECTIF. In ENCEPHALE, 06/2022, n° 3. – p. 313-324. |
| Scarifications à l’adolescence et traitements médicamenteux : un lien possible ? GRANIER E. In INFORMATION PSYCHIATRIQUE, 2022, n° 5. – p. 334-338. |
| Proposition d’un modèle descriptif et thérapeutique du rapport au travail : le modèle AIRE. GRANIER E. In ANNALES MEDICO PSYCHOLOGIQUES, 01/2022, n° 1. – p. 29-36. |
| Vivre avec un haut potentiel. Comprendre les HPI et leurs difficultés pour mieux les accompagner. WURMBERG D ; SCHAEFFER C, ROSSAT ML, LHOMME N, GUILLON MS. – Mardaga, 2022. – 271 p. |
| Abord criminologique des auteurs d’abus sur enfant. WIRRMANN D. – Presses universitaires de Strasbourg, 2022. – p. 251-254. |
| Éléments de sémiologie psychomotrice à partir d’un examen psychomoteur standardisé. TREILLET L, ANNEHEIM N, SIEGRIST I, OTT M. – De Boeck, 2022. – p. 116-164. |
| Monami R. K.G. Dürckheim. La thérapie initiatique. De l’expérience vécue à la théorisation. Journal des psychologues, N°389, juillet-août 2021 |
| Monami R. La question de la mort en prison. Journal des psychologues, N°385, mars 2021 |
| Duval F. First-dose methylphenidate-induced changes in the anti-saccade task performance and outcome in adults with attention-deficit/hyperactivity disorder. Journal of Chemical Biology & Pharmaceutical Chemistry, avril 2021 |
| Duval F, Mokrani MC, Erb A, Gonzalez Lopera F, Danila V, Tomsa M. Neuroendocrine Assessment of Dopaminergic Function during Antidepressant Treatment in Major Depressed Patients. Brain Sciences, 26 mars 2021 |
| Monami R. Du corps en prison. Revue Imaginaire & Inconscient, N°46, « Corps imaginaire, corps réel », novembre 2020 |
| Mokrani MC, Duval F, Erb A, Gonzalez Lopera F, Danila V. Are the thyroid and adrenal system alterations linked in depression ? Psychoneuroendocrinology 122, 11 août 2020 |
| Monami R, Brandt S. L’activité thérapeutique à médiation comme support mimétique à la structuration de la relation : le Tchoukball. Le Journal des Psychologues, N°376, avril 2020 |
| Duval F. Thyroid Hormone Treatment of Mood Disorders. Curr Treat Option Psych DOI 10.1007/s40501-018-0155-z |
| Duval F, Mokrani MC. Thyroid Axis Activity in Depression. Annals Thyroid Res. 2018; 4(3): 166-171. |
| Duval F, Mokrani MC, Erb A, Seassau M, Carcangiu R, Weiss T, Caruso L. Effects of a Single Dose of Methylphenidate on Saccadic Eye Movements in Adults with Attention-Deficit/Hyperactivity Disorder. Neurosci Psychiatry 2018, 1:2 |
| Carcangiu R, Ertlé S, Staner L, Sellal F, Duval F. Comorbidité narcolepsie de type I et épilepsie généralisée idiopathique chez un adolescent. Revue Neurologique 2017,173 (S): 131 |
| Carcangiu R, Ertlé S, Staner L, Sellal F, Duval F. Comorbidté narcolepsie et trouble déficit de l’attention/hyperactivité : effet comparatif du Modafinil et Méthylphenidate dans un cas pédiatrique. Médecine du sommeil, mar. 2017 |
| Guillon MS, Wirrmann D, Bauemle D, Monami R, Wurmberg D. Evaluer le risque suicidaire – Analyse des pratiques professionnelles et dispositif d’évaluation des soins. Gestions hospitalières n°570 – nov. 2017 |
| Duval F, Mokrani MC, Seasseau M, Carcangiu R, Weiss T, Caruso L. Effects of a single low dose of methylphenidate on saccadic eye movements in adults with Attention-Deficit/Hyperactivity Disorder (ADHD). Eur Neuropsychopharmacol. 2017;27S,S1106 |
| Ertle S, Vanoli L, Erb A, Duval F. Effect of a single dose of methylphenidate on cognition in adults with Attention Deficit Hyperactivity Disorders and predictive therapeutic response. Eur Neuropsychopharmacol. 2017;27S,S639 |
| Duval F, Guillon MS, Mokrani MC, Crocq MA. Elevation of prolactin levels by risperidone and olanzapine in adolescents with schizophreniform disorders: correlations with drug plasma concentrations. Psychoneuroendocrinology 2017;83S, 48 |
| Duval F, Mokrani MC, Erb A, Gonzalez Lopera FG, Calleja C, Allouche C. Effect of addition of aripiprazole to antipsychotic treatment on dopaminergic activity in schizophrenic patients. Psychoneuroendocrinology 2017;83S, 47 |
| Duval F, Mokrani MC, Gonzalez Lopera FG, Diep TS, Erb A, Allouche C, Calleja C. Thyroid axis activity and dopamine function in major depression. Psychoneuro-endocrinology 2017;83S, 42 |
| Duval F, Mokrani M.C, Erb A., Gonzalez Lopera F, Calleja C, Paris V. Chronobiological thyrotropin and prolactin responses to protirelin (TRH) : relationship to suicidal behavior in depressed patients. Psychoneuroendocrinology 2017;85:100-109 |
| Du crime aux mœurs / Monami René, Journal des Psychologues de mai 2017, N°347. Télécharger la publication au format PDF |
| Carcangiu R, Staner L, Sellal F, Duval F. Vigilance d’une population Parkinsonienne. Revue Neurologique Avril 2016; Vol 172 (S1): 146 |
| Longue peine et fin de peine entre humeur et liberté – Un réaménagement psychique / Dancoine Julie, Morgenthaler Laurence, Monami René, Journal des Psychologues de février 2016, N°334. Télécharger la publication au format PDF |
| Duval F, Mokrani MC, Erb A, Gonzalez Lopera F, Alexa C, Proudnikova X, Butucaru I. Chronobiological hypothalamic-pituitary-thyroid axis status and antidepressant outcome in major depression / Psychoneuroendocrynology 2015;59:71-80 |
| Duval F, Mokrani MC, Erb A, Lopera FG, Proudnikova X, Paris V. Chronobiological cortisol scretion and dopamine function in major depression / Psychoneuroendocrynology 2015;61:52 |
| Duval F, Mokrani MC, Erb A, Lopera FG, Proudnikova X, Paris V. HPA Axis dysfunction: Is it a trait marker for bipolar disorder? Psychoneuroendocrynology 2015;61:52 |
| Early effects of antidepressant drugs on secretion of prolactin in patients with major depression – Psychoneuroendocrynology 2015;61:52-2 / Duval F, Mokrani MC, Erb A, Lopera FG, Proudnikova X, Paris V |
| Zolpidem sublingual formulations in Guglietta A (ed), Drug Treatment of Sleep Disorders / Staner L. |
| Bénéfice d’une administration sous-cutanée continue d’apomorphine chez un patient atteint d’un syndrome des jambes sans repos sévère / Carcangiu R., Staner L., Sellal F., Gauthier C., Duval F. |
| Recommandations de bonne pratique de la HAS dans le cadre du trouble déficit de l’attention/hyperactivité : non, l’accord d’experts n’équivaut pas à une preuve scientifique établie ! / CLEMENT C, DUTRAY B. In JOURNAL DE THERAPIE COMPORTEMENTALE ET COGNITIVE, 06/2015, n° 2. – p. 39-40 |
| La reconnaissance des émotions chez les auteurs de violence sexuelle : approche différentielle et mise en rapport avec le niveau de conscience de l’acte / Huon P, Rebourg-Roesler C, Tichey C DE, collectif. Annales médico-psychologiques, 03/2015, n°2. – p.153-159. |
| Fabrice Duval, Marie-Claude Mokrani, Alexis Erb,Felix Gonzalez Lopera, Claudia Alexa, Xenia Proudnikova,Iuliana Butucaru. Chronobiological hypothalamic—pituitary—thyroid axis status and antidepressant outcome in major depression. Télécharger l’article au format PDF |
| Histoire des traitements antipsychotiques à action prolongée dans la schizophrénie. / CROCQ MA. In ENCEPHALE, 02/2015, n° 1. – p. 84-92. |
| Briki M, Monnin J, Haffen E, Sechter D, Favrod J, Netillard C, Cheraitia E, Marin K, Govyadovskaya S, Tio G, Bonin B, Chauvet-Gelinier JC, Leclerc S, Hodé Y, Vidailhet P, Berna F, Bertschy AZ, Vandel P. Metacognitive training for schizophrenia: a multicentre randomised controlled trial. Schizophr Res. 2014;157(1-3):99-106. |
| Fabrice Duval, Marie-Claude Mokrani, Alexis Erb, Felix Gonzalez Lopera, Claudia Alexa, Hassen Rabia, Xenia Proudnikova, Iuliana Butucaru. CHRONOBIOLOGICAL HYPOTHALAMIC-PITUITARY-THYROID AXIS STATUS AND ANTIDEPRESSANT OUTCOME IN MAJOR DEPRESSION (Submitted) |
| R. Carcangiu, F. Sellal, L. Staner, C. Quantius-Chiriac, F. Duval. Etude polysomnographique du rythme veille sommeil d’une population de patients atteints d’une maladie de Parkinson idiopathique. Poster. Journées de Neurologie de Langue Française. Strasbourg, avril 2014. Revue Neurologique 2014; Vol 170 (S1): 168-169 |
| Programme francophone de formation pour les parents d’enfants avec un TSA : fondements et contenus / J. ILG, A. PAQUET, L. WOLGENSINGER, B. DUTRAY, M. RIVARD, M. ROUSSEAU, J. FORGET, S. HAUTH-CHARLIER, C. CLEMENT dans RFCCC – Décembre 2014 – Vol XIX – n°3 – p. 20. Télécharger l’article au format PDF |
| L’ISO 26 000 (responsabilité sociétale et développement durable), une norme globale d’écosystème qui donne du sens aux missions de l’hôpital / D. Lachat, directrice adjointe du Centre hospitalier de Rouffach, mars/avril 2014, N°744, Techniques Hospitalières. |
| Informer les familles : une démarche active / CLEMENT C, HODE Y. In SANTE MENTALE, 01/2014, n° 184. – p. 60-63. |
| Sémiotique de l’action chez les auteurs de violences sexuelles et non sexuelles / Huon P, Rebourg-Roesler C, Lighezzolo-Alnot J. Annales médico-psychologiques, 07/2014, n°5. – p.339-344. |
| Présentation d’un atelier littéraire et musical en unité de soin pour adolescents / Guillon MS, Rocton N, Wurmberg D, Schaal CH. Information psychiatrique, 02/2014, n°2. – p.115-120. |
| L’autisme à l’âge adulte : bilan diagnostique et aspects thérapeutiques / Murad A, Fritsch A, Bizet E, Schaal CH. Annales médico-psychologiques, 2014, n°7. – p.587-594. |
| L’autisme à l’âge adulte : aspects cliniques / Murad A, Fritsch A, Bizet E, Schaal CH. Annales médico-psychologiques, 2014, n°7. – p.577-586. |
| Informer les familles : une démarche active / Clement C, Hode Y. Santé mentale, 01/2014, n°184. – p.60-63. |
| Hodé Y. [Psychoeducation of patients and their family members during episode psychosis]. Encephale. 2013 Sep;39 Suppl 2:S110-4. |
| Duval F, Mokrani MC, Crocq MA. What future for neuroendocrinology in psychiatry? Psychoneuroendocrinology. 2013 Aug;38(8):1213-9. |
| Affections métaboliques et psychiatrie / DUVAL F. In EMC Psychiatrie, 04/2013, n° 154. – 37-640-B-10. |
| Jobert M, Wilson FJ, Roth T, Ruigt GS, Anderer P, Drinkenburg WH, Bes FW, Brunovsky M, Danker-Hopfe H, Freeman J, van Gerven JM, Gruber G, Kemp B, Klösch G, Ma J, Penzel T, Peterson BT, Schulz H, Staner L, Saletu B, Svetnik V, IPEG Pharmaco-EEG Guidelines Committee. Guidelines for the recording and evaluation of pharmaco-sleep studies in man: the International Pharmaco-EEG Society (IPEG). Neuropsychobiology. 2013;67(3):127-67. |
| Les intrusions au sein du Moi : psychopathologie de l’exil intérieur dans la maladie d’Alzheimer / Pierron Robinet G. Neurologie, Psychiatrie, Gériatrie, 02/2013, n°73. – p.19-27. |
| Rouffach, premier centre hospitalier public français évalué en ISO 26 000 / D. Lachat, directrice adjointe du centre hospitalier de Rouffach, Avril 2013, Techniques Hospitalières. |
| Profil et traitement des auteurs de violences sexuelles / Dr. D. Wirrmann, psychiatre, adjointe du CRAVS Alsace, M. Hattenberger, psychologue, E.Decker, IDE, CRAVS Alsace Plateforme Sud, décembre 2013, Résoado N°9. |
| Pompili M, Gibiino S, Innamorati M, Serafini G, Del Casale A, De Risio L, Palermo M, Montebovi F, Campi S, De Luca V, Sher L, Tatarelli R, Biondi M, Duval F, Serretti A, Girardi P. Prolactin and thyroid hormone levels are associated with suicide attempts in psychiatric patients. Psychiatry Res. 2012;200:389-394. |
| Bouji M, Lecomte A, Hode Y, de Seze R, Villégier AS. Effects of 900 MHz radiofrequency on corticosterone, emotional memory and neuroinflammation in middle-aged rats. Exp Gerontol. 2012;47(6):444-451. |
| Les thérapies de remédiation cognitive font-elles partie des thérapies cognitivo-comportementales ? / HODE Y, WILLARD M. In JOURNAL DE THERAPIE COMPORTEMENTALE ET COGNITIVE, 09/2012, n° 3. – p. 92-96. |
| Lundahl J, Deacon S, Maurice D, Staner L. EEG spectral power density profiles during NREM sleep for gaboxadol and zolpidem in patients with primary insomnia. J Psychopharmacol. 2012 Aug;26(8):1081-7. |
| Staner L, Danjou P, Luthringer R. A new sublingual formulation of zolpidem for the treatment of sleep-onset insomnia. Expert Rev Neurother. 2012 Feb;12(2):141-53. |
| Une équipe mobile pour les adultes porteurs de troubles du spectre autistique / Connan A, Haegele M, Murad A, Wittner G. Annales médico-psychologiques, 09/2012, n°7. – p.497-501. |
| Gestion de la colère chez les adultes porteurs de troubles du spectre autistique / Murad A, Fritsch A, Lecomte F, Stojanovic J, Haegele M. Annales médico-psychologiques, 09/2012, n°7. – p.494-496. |
| Etude des formes de rupture entre le soma et la psyché dans l’âge avancé à la lumière du concept de Spaltung / Pierron Robinet G. Neurologie, Psychiatrie, Gériatrie, 04/2012, n°68. – p.74-83. |
| Pour une approche intégrative de la maladie d’Alzheimer. Pertinence et limites / Pierron Robinet G. Gériatrie et psychologie, neuropsychiatrie du vieillissement, 03/2012, n°1. – p.73-81. |
| Les deuils pathologiques différés en psychiatrie de l’âge avancé : clinique et psychopathologie / Pierron Robinet G. Neurologie, Psychiatrie, Gériatrie, 02/2012, n°67. – p.35-42. |
| Evaluation chez les adultes de la trace psychomotrice des pathologies psychiatriques / Treillet L, Mechler I, Rieg M, Anneheim N. Thérapie psychomotrice et recherches, 2012, n°169. – p.88-97. |
| Greenblatt DJ, Harmatz JS, Walsh JK, Luthringer R, Staner L, Otmani S, Nedelec JF, Francart C, Parent SJ, Staner C. Pharmacokinetic profile of SKP-1041, a modified release formulation of zaleplon. Biopharm Drug Dispos. 2011 Dec;32(9):489-97. |
| Hodé Y, Benyamina A, Arbus C, Reimold M. Active cyamemazine metabolites in patients treated with cyamemazine (Tercian®): influence on cerebral dopamine D2 and serotonin 5-HT (2A) receptor occupancy as measured by positron emission tomography (PET). Psychopharmacology (Berl). 2011 Oct;217(3):315-21. |
| Ferber G, Staner L, Boeijinga P. Structured multiplicity and confirmatory statistical analyses in pharmacodynamic studies using the quantitative electroencephalogram. J Neurosci Methods. 2011 Sep 30;201(1):204-12. |
| Tecco J, Monreal J, Staner L. Citalopram may reduce sympathoadrenal hyperactivity in elderly depressed patients: an open multicenter study in Belgium and Luxembourg. Psychiatr Danub. 2011 Sep;23 Suppl 1:S35-42. |
| Intégrer les proches : pourquoi, comment / HODE Y. In SANTE MENTALE, 06/2011, n° 159. – p. 64-67. |
| Prise en charge des familles de patients schizophrènes / HODE Y. In ANNALES MEDICO-PSYCHOLOGIQUES, 04/2011, n° 3. – p. 196-199. |
| Schunck T, Mathis A, Erb G, Namer IJ, Hode Y, Demazières A, Luthringer R. One milligram of lorazepam does not decrease anxiety induced by CCK-4 in healthy volunteers: investigation of neural correlates with BOLD MRI. J Psychopharmacol. 2011 Jan;25(1):52-9. |
| Profamille en action / Huentz M, Vonthron R. Santé mentale, 06/2011, n°159. – p.68-71. |
| Démarche de certification intégrée des normes ISO 20000:2005 et ISO 9001:2008 de la direction des systèmes d’information du centre hospitalier de Rouffach / Ebele F, Flesch L. Techniques hospitalières, 06/2011, n°727. – p.36-39. |
| Les activités thérapeutiques à médiation / Hensgen E, Lefret M, Brandt S, Saliot L. Gestions hospitalières, 05/2011, n°506. – p.323-328. |
| Le vieillissement entre risque et désir, Harold et Maude : une image de résilience ? / Pierron Robinet G. Journal des psychologues, 04/2011, n°286. – p.47-51. |
| Une psychothérapie à médiation olfactive en psychiatrie de l’âge avancé / Pierron Robinet G. Revue française de psychiatrie et de psychologie médicale, 03/2011, n°116. – p.12-20. |
| Figures du clivage dans l’oubli : d’une amnésie rétrograde à la maladie d’Alzheimer / Pierron Robinet G. Neurologie, Psychiatrie, Gériatrie, 2011, n°65. – p.214-220. |
| Duval F, Mokrani MC, Lopera FG, Diep TS, Rabia H, Fattah S. Thyroid axis activity and suicidal behavior in depressed patients. Psychoneuroendocrinology. 2010 Aug;35(7):1045-54. |
| Staner C, Joly F, Jacquot N, Vlasova ID, Nehlin M, Lundqvist T, Edenius C, Staner L. Sublingual zolpidem in early onset of sleep compared to oral zolpidem: polysomnographic study in patients with primary insomnia. Curr Med Res Opin. 2010 Jun;26(6):1423-31. |
| Staner L. Comorbidity of insomnia and depression. Sleep Med Rev. 2010 Feb;14(1):35-46. |
| Quelle place pour l’absence ? Le délire du sujet âgé en question / Pierron Robinet G. Journal des psychologues, 09/2010, n° 280. – p.59-63. |
| « Alice au Pays des merveilles » – Une création « culture à l’hôpital » transfrontalière / Lachat D. Revue Hospitalière de France, 08/2010, n°535. – p.61-63. |
| Trieste : 30 ans après la fermeture de son hôpital psychiatrique, un exemple pour le développement durable et l’insertion sociétale. D. Lachat, Directrice de la Clientèle et de la Communication, Centre hospitalier de Rouffach (France 68) |
| Luthringer R, Muzet M, Zisapel N, Staner L. The effect of prolonged-release melatonin on sleep measures and psychomotor performance in elderly patients with insomnia. Int Clin Psychopharmacol. 2009 Sep;24(5):239-49. |
| Staner L, Eriksson M, Cornette F, Santoro F, Muscat N, Luthinger R, Roth T. Sublingual zolpidem is more effective than oral zolpidem in initiating early onset of sleep in the post-nap model of transient insomnia: a polysomnographic study. Sleep Med. 2009 Jun;10(6):616-20. |
| Le Bon O, Hoffmann R, Staner L, Armitage R. Relationships between the number of ultradian cycles and key sleep variables in outpatients with major depressive disorder. Psychiatry Res. 2009 Jan 30;165(1-2):60-7. |
| L’entraînement aux habiletés sociales chez les adultes avec autisme / Fritsch A, Murad A, Kloss S, Francescon-Rota G, Bizet E. Annales Médico-Psychologiques, 05/2009, n°4. – p.299-302. |
| Otmani S, Demazières A, Staner C, Jacob N, Nir T, Zisapel N, Staner L. Effects of prolonged-release melatonin, zolpidem, and their combination on psychomotor functions, memory recall, and driving skills in healthy middle aged and elderly volunteers. Hum Psychopharmacol. 2008 Dec;23(8):693-705. |
| Effet d’un programme psychoéducatif sur l’humeur des familles des malades souffrant de schizophrénie / HODE Y, KRYCHOWSKI R, PASCHE P, COLLECTIF. In JOURNAL DE THERAPIE COMPORTEMENTALE ET COGNITIVE, 09/2008, n° 3. – p. 104-107. |
| Trémeau F, Darreye A, Staner L, Corrêa H, Weibel H, Khidichian F, Macher JP. Suicidality in opioid-dependent subjects. Am J Addict. 2008 May-Jun;17(3):187-94. |
| Duval F, Guillon MS, Mokrani MC, Crocq MA, Garcia Duarte F. Relationship between prolactin secretion, and plasma risperidone and 9-hydroxyrisperidone concentrations in adolescents with schizophreniform disorder. Psychoneuroendocrinology. 2008 Feb;33(2):255-9. |
| Duval F. Cortisol hypersecretion in unipolar major depression with melancholic and psychotic features: dopaminergic, noradrenergic and thyroid correlates. Psychoneuroendocrinology. 2007;32:211-212 (author reply). |
| Lundahl J, Staner L, Staner C, Loft H, Deacon S. Short-term treatment with gaboxadol improves sleep maintenance and enhances slow wave sleep in adult patients with primary insomnia. Psychopharmacology (Berl). 2007 Nov;195(1):139-46. |
| Luthringer R, Staner L, Noel N, Muzet M, Gassmann-Mayer C, Talluri K, Cleton A, Eerdekens M, Battisti WP, Palumbo JM. A double-blind, placebo-controlled, randomized study evaluating the effect of paliperidone extended-release tablets on sleep architecture in patients with schizophrenia. Int Clin Psychopharmacol. 2007 Sep;22(5):299-308. |
| Deacon S, Staner L, Staner C, Legters A, Loft H, Lundahl J. Effect of short-term treatment with gaboxadol on sleep maintenance and initiation in patients with primary insomnia. Sleep. 2007 Mar;30(3):281-7. |
| Chouvarda I, Papadelis C, Domis N, Staner L, Maglaveras N. Insomnia treatment assessment based on physiological data analysis. Conf Proc IEEE Eng Med Biol Soc. 2007;2007:6695-7. |
| De Rouffach à Colmar, une fresque pour accompagner le passage / A. Damen, chargée de communication au centre hospitalier de Rouffach, septembre/octobre 2007, N°518, Revue Cultures et Cités. |
| Staner L, Boeijinga P, Danel T, Gendre I, Muzet M, Landron F, Luthringer R. Effects of acamprosate on sleep during alcohol withdrawal: A double-blind placebo-controlled polysomnographic study in alcohol-dependent subjects. Alcohol Clin Exp Res. 2006 Sep;30(9):1492-9. |
| Duval F, Mokrani MC, Monreal-Ortiz JA, Fattah S, Champeval C, Schulz P, Macher JP. Cortisol hypersecretion in unipolar major depression with melancholic and psychotic features: dopaminergic, noradrenergic and thyroid correlates. Psychoneuroendocrinology. 2006 Aug;31(7):876-88. |
| Schunck T, Erb G, Mathis A, Gilles C, Namer IJ, Hode Y, Demaziere A, Luthringer R, Macher JP. Functional magnetic resonance imaging characterization of CCK-4-induced panic attack and subsequent anticipatory anxiety. Neuroimage. 2006 Jul 1;31(3):1197-208. |
| Staner L, Luthringer R, Dupont C, Aubin HJ, Lagrue G. Sleep effects of a 24-h versus a 16-h nicotine patch: a polysomnographic study during smoking cessation. Sleep Med. 2006 Mar;7(2):147-54. |
| Duval F, Lebowitz BD, Macher JP. Treatments in depression. Dialogues Clin Neurosci. 2006;8(2):191-206. |
| Staner L. Surrogate outcomes in neurology, psychiatry, and psychopharmacology. Dialogues Clin Neurosci. 2006;8(3):345-52. |
| De l’intérêt de la remédiation cognitive / HODE Y. In SANTE MENTALE, 03/2006, n° 106. – pp 78-81. |
| Duval, F. (2023). Systematic Review of the Apomorphine Challenge Test in the Assessment of Dopaminergic Activity in Schizophrenia. Healthcare, 11(10), 1487. https://doi.org/10.3390/healthcare11101487 |
| Duval, F., Mokrani, M.-C., Danila, V., Lopera, F. G., Erb, A., & Tomsa, M. (2023). Hypothalamic-prolactin axis regulation in major depressed patients with suicidal behavior. Psychoneuroendocrinology, 151, 106050. https://doi.org/10.1016/j.psyneuen.2023.106050 |
| Duval F, Mokrani MC, Danila V, Erb A, Gonzalez Lopera F, Tomsa M. Dopamine Function and Hypothalamic-Pituitary-Thyroid Axis Activity in Major Depressed Patients with Suicidal Behavior. Brain Sci.2022,12,621. https://doi.org/10.3390/brainsci12050621 |
| Duval F, Mokrani MC, Danila V, Erb A, Gonzalez Lopera F, Tomsa M. Effect of repetitive transcranial magnetic stimulation on chronobiological hypothalamic-pituitary-thyroid axis activity in major depression. Biol Psychiatry 2022;91:S205 |
| Duval F, Mokrani MC, Danila V, Erb A, Gonzalez Lopera F, Tomsa M. Thyroid Axis Activity and Dopamine Function in Major Depressed Patients with Suicidal Behavior. Biol Psychiatry 2022;91:S376 |
| Les échelles anticholinergiques : usage en psychiatrie et mise à jour de l’échelle d’imprégnation anticholinergique. JAVELOT H, MEYER G, BECKER G, POST G, POSPIESZYNSKI P, COLLECTIF. In ENCEPHALE, 06/2022, n° 3. – p. 313-324. |
| Scarifications à l’adolescence et traitements médicamenteux : un lien possible ? GRANIER E. In INFORMATION PSYCHIATRIQUE, 2022, n° 5. – p. 334-338. |
| Proposition d’un modèle descriptif et thérapeutique du rapport au travail : le modèle AIRE. GRANIER E. In ANNALES MEDICO PSYCHOLOGIQUES, 01/2022, n° 1. – p. 29-36. |
| Vivre avec un haut potentiel. Comprendre les HPI et leurs difficultés pour mieux les accompagner. WURMBERG D ; SCHAEFFER C, ROSSAT ML, LHOMME N, GUILLON MS. – Mardaga, 2022. – 271 p. |
| Abord criminologique des auteurs d’abus sur enfant. WIRRMANN D. – Presses universitaires de Strasbourg, 2022. – p. 251-254. |
| Éléments de sémiologie psychomotrice à partir d’un examen psychomoteur standardisé. TREILLET L, ANNEHEIM N, SIEGRIST I, OTT M. – De Boeck, 2022. – p. 116-164. |
| Monami R. K.G. Dürckheim. La thérapie initiatique. De l’expérience vécue à la théorisation. Journal des psychologues, N°389, juillet-août 2021 |
| Monami R. La question de la mort en prison. Journal des psychologues, N°385, mars 2021 |
| Duval F. First-dose methylphenidate-induced changes in the anti-saccade task performance and outcome in adults with attention-deficit/hyperactivity disorder. Journal of Chemical Biology & Pharmaceutical Chemistry, avril 2021 |
| Duval F, Mokrani MC, Erb A, Gonzalez Lopera F, Danila V, Tomsa M. Neuroendocrine Assessment of Dopaminergic Function during Antidepressant Treatment in Major Depressed Patients. Brain Sciences, 26 mars 2021 |
| Monami R. Du corps en prison. Revue Imaginaire & Inconscient, N°46, « Corps imaginaire, corps réel », novembre 2020 |
| Mokrani MC, Duval F, Erb A, Gonzalez Lopera F, Danila V. Are the thyroid and adrenal system alterations linked in depression ? Psychoneuroendocrinology 122, 11 août 2020 |
| Monami R, Brandt S. L’activité thérapeutique à médiation comme support mimétique à la structuration de la relation : le Tchoukball. Le Journal des Psychologues, N°376, avril 2020 |
| Duval F. Thyroid Hormone Treatment of Mood Disorders. Curr Treat Option Psych DOI 10.1007/s40501-018-0155-z |
| Duval F, Mokrani MC. Thyroid Axis Activity in Depression. Annals Thyroid Res. 2018; 4(3): 166-171. |
| Duval F, Mokrani MC, Erb A, Seassau M, Carcangiu R, Weiss T, Caruso L. Effects of a Single Dose of Methylphenidate on Saccadic Eye Movements in Adults with Attention-Deficit/Hyperactivity Disorder. Neurosci Psychiatry 2018, 1:2 |
| Carcangiu R, Ertlé S, Staner L, Sellal F, Duval F. Comorbidité narcolepsie de type I et épilepsie généralisée idiopathique chez un adolescent. Revue Neurologique 2017,173 (S): 131 |
| Carcangiu R, Ertlé S, Staner L, Sellal F, Duval F. Comorbidté narcolepsie et trouble déficit de l’attention/hyperactivité : effet comparatif du Modafinil et Méthylphenidate dans un cas pédiatrique. Médecine du sommeil, mar. 2017 |
| Guillon MS, Wirrmann D, Bauemle D, Monami R, Wurmberg D. Evaluer le risque suicidaire – Analyse des pratiques professionnelles et dispositif d’évaluation des soins. Gestions hospitalières n°570 – nov. 2017 |
| Duval F, Mokrani MC, Seasseau M, Carcangiu R, Weiss T, Caruso L. Effects of a single low dose of methylphenidate on saccadic eye movements in adults with Attention-Deficit/Hyperactivity Disorder (ADHD). Eur Neuropsychopharmacol. 2017;27S,S1106 |
| Ertle S, Vanoli L, Erb A, Duval F. Effect of a single dose of methylphenidate on cognition in adults with Attention Deficit Hyperactivity Disorders and predictive therapeutic response. Eur Neuropsychopharmacol. 2017;27S,S639 |
| Duval F, Guillon MS, Mokrani MC, Crocq MA. Elevation of prolactin levels by risperidone and olanzapine in adolescents with schizophreniform disorders: correlations with drug plasma concentrations. Psychoneuroendocrinology 2017;83S, 48 |
| Duval F, Mokrani MC, Erb A, Gonzalez Lopera FG, Calleja C, Allouche C. Effect of addition of aripiprazole to antipsychotic treatment on dopaminergic activity in schizophrenic patients. Psychoneuroendocrinology 2017;83S, 47 |
| Duval F, Mokrani MC, Gonzalez Lopera FG, Diep TS, Erb A, Allouche C, Calleja C. Thyroid axis activity and dopamine function in major depression. Psychoneuro-endocrinology 2017;83S, 42 |
| Duval F, Mokrani M.C, Erb A., Gonzalez Lopera F, Calleja C, Paris V. Chronobiological thyrotropin and prolactin responses to protirelin (TRH) : relationship to suicidal behavior in depressed patients. Psychoneuroendocrinology 2017;85:100-109 |
| Du crime aux mœurs / Monami René, Journal des Psychologues de mai 2017, N°347. Télécharger la publication au format PDF |
| Carcangiu R, Staner L, Sellal F, Duval F. Vigilance d’une population Parkinsonienne. Revue Neurologique Avril 2016; Vol 172 (S1): 146 |
| Longue peine et fin de peine entre humeur et liberté – Un réaménagement psychique / Dancoine Julie, Morgenthaler Laurence, Monami René, Journal des Psychologues de février 2016, N°334. Télécharger la publication au format PDF |
| Duval F, Mokrani MC, Erb A, Gonzalez Lopera F, Alexa C, Proudnikova X, Butucaru I. Chronobiological hypothalamic-pituitary-thyroid axis status and antidepressant outcome in major depression / Psychoneuroendocrynology 2015;59:71-80 |
| Duval F, Mokrani MC, Erb A, Lopera FG, Proudnikova X, Paris V. Chronobiological cortisol scretion and dopamine function in major depression / Psychoneuroendocrynology 2015;61:52 |
| Duval F, Mokrani MC, Erb A, Lopera FG, Proudnikova X, Paris V. HPA Axis dysfunction: Is it a trait marker for bipolar disorder? Psychoneuroendocrynology 2015;61:52 |
| Early effects of antidepressant drugs on secretion of prolactin in patients with major depression – Psychoneuroendocrynology 2015;61:52-2 / Duval F, Mokrani MC, Erb A, Lopera FG, Proudnikova X, Paris V |
| Zolpidem sublingual formulations in Guglietta A (ed), Drug Treatment of Sleep Disorders / Staner L. |
| Bénéfice d’une administration sous-cutanée continue d’apomorphine chez un patient atteint d’un syndrome des jambes sans repos sévère / Carcangiu R., Staner L., Sellal F., Gauthier C., Duval F. |
| Recommandations de bonne pratique de la HAS dans le cadre du trouble déficit de l’attention/hyperactivité : non, l’accord d’experts n’équivaut pas à une preuve scientifique établie ! / CLEMENT C, DUTRAY B. In JOURNAL DE THERAPIE COMPORTEMENTALE ET COGNITIVE, 06/2015, n° 2. – p. 39-40 |
| La reconnaissance des émotions chez les auteurs de violence sexuelle : approche différentielle et mise en rapport avec le niveau de conscience de l’acte / Huon P, Rebourg-Roesler C, Tichey C DE, collectif. Annales médico-psychologiques, 03/2015, n°2. – p.153-159. |
| Fabrice Duval, Marie-Claude Mokrani, Alexis Erb,Felix Gonzalez Lopera, Claudia Alexa, Xenia Proudnikova,Iuliana Butucaru. Chronobiological hypothalamic—pituitary—thyroid axis status and antidepressant outcome in major depression. Télécharger l’article au format PDF |
| Histoire des traitements antipsychotiques à action prolongée dans la schizophrénie. / CROCQ MA. In ENCEPHALE, 02/2015, n° 1. – p. 84-92. |
| Briki M, Monnin J, Haffen E, Sechter D, Favrod J, Netillard C, Cheraitia E, Marin K, Govyadovskaya S, Tio G, Bonin B, Chauvet-Gelinier JC, Leclerc S, Hodé Y, Vidailhet P, Berna F, Bertschy AZ, Vandel P. Metacognitive training for schizophrenia: a multicentre randomised controlled trial. Schizophr Res. 2014;157(1-3):99-106. |
| Fabrice Duval, Marie-Claude Mokrani, Alexis Erb, Felix Gonzalez Lopera, Claudia Alexa, Hassen Rabia, Xenia Proudnikova, Iuliana Butucaru. CHRONOBIOLOGICAL HYPOTHALAMIC-PITUITARY-THYROID AXIS STATUS AND ANTIDEPRESSANT OUTCOME IN MAJOR DEPRESSION (Submitted) |
| R. Carcangiu, F. Sellal, L. Staner, C. Quantius-Chiriac, F. Duval. Etude polysomnographique du rythme veille sommeil d’une population de patients atteints d’une maladie de Parkinson idiopathique. Poster. Journées de Neurologie de Langue Française. Strasbourg, avril 2014. Revue Neurologique 2014; Vol 170 (S1): 168-169 |
| Programme francophone de formation pour les parents d’enfants avec un TSA : fondements et contenus / J. ILG, A. PAQUET, L. WOLGENSINGER, B. DUTRAY, M. RIVARD, M. ROUSSEAU, J. FORGET, S. HAUTH-CHARLIER, C. CLEMENT dans RFCCC – Décembre 2014 – Vol XIX – n°3 – p. 20. Télécharger l’article au format PDF |
| L’ISO 26 000 (responsabilité sociétale et développement durable), une norme globale d’écosystème qui donne du sens aux missions de l’hôpital / D. Lachat, directrice adjointe du Centre hospitalier de Rouffach, mars/avril 2014, N°744, Techniques Hospitalières. |
| Informer les familles : une démarche active / CLEMENT C, HODE Y. In SANTE MENTALE, 01/2014, n° 184. – p. 60-63. |
| Sémiotique de l’action chez les auteurs de violences sexuelles et non sexuelles / Huon P, Rebourg-Roesler C, Lighezzolo-Alnot J. Annales médico-psychologiques, 07/2014, n°5. – p.339-344. |
| Présentation d’un atelier littéraire et musical en unité de soin pour adolescents / Guillon MS, Rocton N, Wurmberg D, Schaal CH. Information psychiatrique, 02/2014, n°2. – p.115-120. |
| L’autisme à l’âge adulte : bilan diagnostique et aspects thérapeutiques / Murad A, Fritsch A, Bizet E, Schaal CH. Annales médico-psychologiques, 2014, n°7. – p.587-594. |
| L’autisme à l’âge adulte : aspects cliniques / Murad A, Fritsch A, Bizet E, Schaal CH. Annales médico-psychologiques, 2014, n°7. – p.577-586. |
| Informer les familles : une démarche active / Clement C, Hode Y. Santé mentale, 01/2014, n°184. – p.60-63. |
| Hodé Y. [Psychoeducation of patients and their family members during episode psychosis]. Encephale. 2013 Sep;39 Suppl 2:S110-4. |
| Duval F, Mokrani MC, Crocq MA. What future for neuroendocrinology in psychiatry? Psychoneuroendocrinology. 2013 Aug;38(8):1213-9. |
| Affections métaboliques et psychiatrie / DUVAL F. In EMC Psychiatrie, 04/2013, n° 154. – 37-640-B-10. |
| Jobert M, Wilson FJ, Roth T, Ruigt GS, Anderer P, Drinkenburg WH, Bes FW, Brunovsky M, Danker-Hopfe H, Freeman J, van Gerven JM, Gruber G, Kemp B, Klösch G, Ma J, Penzel T, Peterson BT, Schulz H, Staner L, Saletu B, Svetnik V, IPEG Pharmaco-EEG Guidelines Committee. Guidelines for the recording and evaluation of pharmaco-sleep studies in man: the International Pharmaco-EEG Society (IPEG). Neuropsychobiology. 2013;67(3):127-67. |
| Les intrusions au sein du Moi : psychopathologie de l’exil intérieur dans la maladie d’Alzheimer / Pierron Robinet G. Neurologie, Psychiatrie, Gériatrie, 02/2013, n°73. – p.19-27. |
| Rouffach, premier centre hospitalier public français évalué en ISO 26 000 / D. Lachat, directrice adjointe du centre hospitalier de Rouffach, Avril 2013, Techniques Hospitalières. |
| Profil et traitement des auteurs de violences sexuelles / Dr. D. Wirrmann, psychiatre, adjointe du CRAVS Alsace, M. Hattenberger, psychologue, E.Decker, IDE, CRAVS Alsace Plateforme Sud, décembre 2013, Résoado N°9. |
| Pompili M, Gibiino S, Innamorati M, Serafini G, Del Casale A, De Risio L, Palermo M, Montebovi F, Campi S, De Luca V, Sher L, Tatarelli R, Biondi M, Duval F, Serretti A, Girardi P. Prolactin and thyroid hormone levels are associated with suicide attempts in psychiatric patients. Psychiatry Res. 2012;200:389-394. |
| Bouji M, Lecomte A, Hode Y, de Seze R, Villégier AS. Effects of 900 MHz radiofrequency on corticosterone, emotional memory and neuroinflammation in middle-aged rats. Exp Gerontol. 2012;47(6):444-451. |
| Les thérapies de remédiation cognitive font-elles partie des thérapies cognitivo-comportementales ? / HODE Y, WILLARD M. In JOURNAL DE THERAPIE COMPORTEMENTALE ET COGNITIVE, 09/2012, n° 3. – p. 92-96. |
| Lundahl J, Deacon S, Maurice D, Staner L. EEG spectral power density profiles during NREM sleep for gaboxadol and zolpidem in patients with primary insomnia. J Psychopharmacol. 2012 Aug;26(8):1081-7. |
| Staner L, Danjou P, Luthringer R. A new sublingual formulation of zolpidem for the treatment of sleep-onset insomnia. Expert Rev Neurother. 2012 Feb;12(2):141-53. |
| Une équipe mobile pour les adultes porteurs de troubles du spectre autistique / Connan A, Haegele M, Murad A, Wittner G. Annales médico-psychologiques, 09/2012, n°7. – p.497-501. |
| Gestion de la colère chez les adultes porteurs de troubles du spectre autistique / Murad A, Fritsch A, Lecomte F, Stojanovic J, Haegele M. Annales médico-psychologiques, 09/2012, n°7. – p.494-496. |
| Etude des formes de rupture entre le soma et la psyché dans l’âge avancé à la lumière du concept de Spaltung / Pierron Robinet G. Neurologie, Psychiatrie, Gériatrie, 04/2012, n°68. – p.74-83. |
| Pour une approche intégrative de la maladie d’Alzheimer. Pertinence et limites / Pierron Robinet G. Gériatrie et psychologie, neuropsychiatrie du vieillissement, 03/2012, n°1. – p.73-81. |
| Les deuils pathologiques différés en psychiatrie de l’âge avancé : clinique et psychopathologie / Pierron Robinet G. Neurologie, Psychiatrie, Gériatrie, 02/2012, n°67. – p.35-42. |
| Evaluation chez les adultes de la trace psychomotrice des pathologies psychiatriques / Treillet L, Mechler I, Rieg M, Anneheim N. Thérapie psychomotrice et recherches, 2012, n°169. – p.88-97. |
| Greenblatt DJ, Harmatz JS, Walsh JK, Luthringer R, Staner L, Otmani S, Nedelec JF, Francart C, Parent SJ, Staner C. Pharmacokinetic profile of SKP-1041, a modified release formulation of zaleplon. Biopharm Drug Dispos. 2011 Dec;32(9):489-97. |
| Hodé Y, Benyamina A, Arbus C, Reimold M. Active cyamemazine metabolites in patients treated with cyamemazine (Tercian®): influence on cerebral dopamine D2 and serotonin 5-HT (2A) receptor occupancy as measured by positron emission tomography (PET). Psychopharmacology (Berl). 2011 Oct;217(3):315-21. |
| Ferber G, Staner L, Boeijinga P. Structured multiplicity and confirmatory statistical analyses in pharmacodynamic studies using the quantitative electroencephalogram. J Neurosci Methods. 2011 Sep 30;201(1):204-12. |
| Tecco J, Monreal J, Staner L. Citalopram may reduce sympathoadrenal hyperactivity in elderly depressed patients: an open multicenter study in Belgium and Luxembourg. Psychiatr Danub. 2011 Sep;23 Suppl 1:S35-42. |
| Intégrer les proches : pourquoi, comment / HODE Y. In SANTE MENTALE, 06/2011, n° 159. – p. 64-67. |
| Prise en charge des familles de patients schizophrènes / HODE Y. In ANNALES MEDICO-PSYCHOLOGIQUES, 04/2011, n° 3. – p. 196-199. |
| Schunck T, Mathis A, Erb G, Namer IJ, Hode Y, Demazières A, Luthringer R. One milligram of lorazepam does not decrease anxiety induced by CCK-4 in healthy volunteers: investigation of neural correlates with BOLD MRI. J Psychopharmacol. 2011 Jan;25(1):52-9. |
| Profamille en action / Huentz M, Vonthron R. Santé mentale, 06/2011, n°159. – p.68-71. |
| Démarche de certification intégrée des normes ISO 20000:2005 et ISO 9001:2008 de la direction des systèmes d’information du centre hospitalier de Rouffach / Ebele F, Flesch L. Techniques hospitalières, 06/2011, n°727. – p.36-39. |
| Les activités thérapeutiques à médiation / Hensgen E, Lefret M, Brandt S, Saliot L. Gestions hospitalières, 05/2011, n°506. – p.323-328. |
| Le vieillissement entre risque et désir, Harold et Maude : une image de résilience ? / Pierron Robinet G. Journal des psychologues, 04/2011, n°286. – p.47-51. |
| Une psychothérapie à médiation olfactive en psychiatrie de l’âge avancé / Pierron Robinet G. Revue française de psychiatrie et de psychologie médicale, 03/2011, n°116. – p.12-20. |
| Figures du clivage dans l’oubli : d’une amnésie rétrograde à la maladie d’Alzheimer / Pierron Robinet G. Neurologie, Psychiatrie, Gériatrie, 2011, n°65. – p.214-220. |
| Duval F, Mokrani MC, Lopera FG, Diep TS, Rabia H, Fattah S. Thyroid axis activity and suicidal behavior in depressed patients. Psychoneuroendocrinology. 2010 Aug;35(7):1045-54. |
| Staner C, Joly F, Jacquot N, Vlasova ID, Nehlin M, Lundqvist T, Edenius C, Staner L. Sublingual zolpidem in early onset of sleep compared to oral zolpidem: polysomnographic study in patients with primary insomnia. Curr Med Res Opin. 2010 Jun;26(6):1423-31. |
| Staner L. Comorbidity of insomnia and depression. Sleep Med Rev. 2010 Feb;14(1):35-46. |
| Quelle place pour l’absence ? Le délire du sujet âgé en question / Pierron Robinet G. Journal des psychologues, 09/2010, n° 280. – p.59-63. |
| « Alice au Pays des merveilles » – Une création « culture à l’hôpital » transfrontalière / Lachat D. Revue Hospitalière de France, 08/2010, n°535. – p.61-63. |
| Trieste : 30 ans après la fermeture de son hôpital psychiatrique, un exemple pour le développement durable et l’insertion sociétale. D. Lachat, Directrice de la Clientèle et de la Communication, Centre hospitalier de Rouffach (France 68) |
| Luthringer R, Muzet M, Zisapel N, Staner L. The effect of prolonged-release melatonin on sleep measures and psychomotor performance in elderly patients with insomnia. Int Clin Psychopharmacol. 2009 Sep;24(5):239-49. |
| Staner L, Eriksson M, Cornette F, Santoro F, Muscat N, Luthinger R, Roth T. Sublingual zolpidem is more effective than oral zolpidem in initiating early onset of sleep in the post-nap model of transient insomnia: a polysomnographic study. Sleep Med. 2009 Jun;10(6):616-20. |
| Le Bon O, Hoffmann R, Staner L, Armitage R. Relationships between the number of ultradian cycles and key sleep variables in outpatients with major depressive disorder. Psychiatry Res. 2009 Jan 30;165(1-2):60-7. |
| L’entraînement aux habiletés sociales chez les adultes avec autisme / Fritsch A, Murad A, Kloss S, Francescon-Rota G, Bizet E. Annales Médico-Psychologiques, 05/2009, n°4. – p.299-302. |
| Otmani S, Demazières A, Staner C, Jacob N, Nir T, Zisapel N, Staner L. Effects of prolonged-release melatonin, zolpidem, and their combination on psychomotor functions, memory recall, and driving skills in healthy middle aged and elderly volunteers. Hum Psychopharmacol. 2008 Dec;23(8):693-705. |
| Effet d’un programme psychoéducatif sur l’humeur des familles des malades souffrant de schizophrénie / HODE Y, KRYCHOWSKI R, PASCHE P, COLLECTIF. In JOURNAL DE THERAPIE COMPORTEMENTALE ET COGNITIVE, 09/2008, n° 3. – p. 104-107. |
| Trémeau F, Darreye A, Staner L, Corrêa H, Weibel H, Khidichian F, Macher JP. Suicidality in opioid-dependent subjects. Am J Addict. 2008 May-Jun;17(3):187-94. |
| Duval F, Guillon MS, Mokrani MC, Crocq MA, Garcia Duarte F. Relationship between prolactin secretion, and plasma risperidone and 9-hydroxyrisperidone concentrations in adolescents with schizophreniform disorder. Psychoneuroendocrinology. 2008 Feb;33(2):255-9. |
| Duval F. Cortisol hypersecretion in unipolar major depression with melancholic and psychotic features: dopaminergic, noradrenergic and thyroid correlates. Psychoneuroendocrinology. 2007;32:211-212 (author reply). |
| Lundahl J, Staner L, Staner C, Loft H, Deacon S. Short-term treatment with gaboxadol improves sleep maintenance and enhances slow wave sleep in adult patients with primary insomnia. Psychopharmacology (Berl). 2007 Nov;195(1):139-46. |
| Luthringer R, Staner L, Noel N, Muzet M, Gassmann-Mayer C, Talluri K, Cleton A, Eerdekens M, Battisti WP, Palumbo JM. A double-blind, placebo-controlled, randomized study evaluating the effect of paliperidone extended-release tablets on sleep architecture in patients with schizophrenia. Int Clin Psychopharmacol. 2007 Sep;22(5):299-308. |
| Deacon S, Staner L, Staner C, Legters A, Loft H, Lundahl J. Effect of short-term treatment with gaboxadol on sleep maintenance and initiation in patients with primary insomnia. Sleep. 2007 Mar;30(3):281-7. |
| Chouvarda I, Papadelis C, Domis N, Staner L, Maglaveras N. Insomnia treatment assessment based on physiological data analysis. Conf Proc IEEE Eng Med Biol Soc. 2007;2007:6695-7. |
| De Rouffach à Colmar, une fresque pour accompagner le passage / A. Damen, chargée de communication au centre hospitalier de Rouffach, septembre/octobre 2007, N°518, Revue Cultures et Cités. |
| Staner L, Boeijinga P, Danel T, Gendre I, Muzet M, Landron F, Luthringer R. Effects of acamprosate on sleep during alcohol withdrawal: A double-blind placebo-controlled polysomnographic study in alcohol-dependent subjects. Alcohol Clin Exp Res. 2006 Sep;30(9):1492-9. |
| Duval F, Mokrani MC, Monreal-Ortiz JA, Fattah S, Champeval C, Schulz P, Macher JP. Cortisol hypersecretion in unipolar major depression with melancholic and psychotic features: dopaminergic, noradrenergic and thyroid correlates. Psychoneuroendocrinology. 2006 Aug;31(7):876-88. |
| Schunck T, Erb G, Mathis A, Gilles C, Namer IJ, Hode Y, Demaziere A, Luthringer R, Macher JP. Functional magnetic resonance imaging characterization of CCK-4-induced panic attack and subsequent anticipatory anxiety. Neuroimage. 2006 Jul 1;31(3):1197-208. |
| Staner L, Luthringer R, Dupont C, Aubin HJ, Lagrue G. Sleep effects of a 24-h versus a 16-h nicotine patch: a polysomnographic study during smoking cessation. Sleep Med. 2006 Mar;7(2):147-54. |
| Duval F, Lebowitz BD, Macher JP. Treatments in depression. Dialogues Clin Neurosci. 2006;8(2):191-206. |
| Staner L. Surrogate outcomes in neurology, psychiatry, and psychopharmacology. Dialogues Clin Neurosci. 2006;8(3):345-52. |
| De l’intérêt de la remédiation cognitive / HODE Y. In SANTE MENTALE, 03/2006, n° 106. – pp 78-81. |
| Trémeau F, Malaspina D, Duval F, Correa H, Hager-Budny M, Coin-Bariou L, Macher JP, Gorman J. Facial expressiveness in patients with schizophrenia, as compared to depressed patients and nonpatient controls. Am J Psychiatry 2005;162:92-101 |
| Trémeau F, Staner L, Duval F, Corrêa H, Crocq MA, Darreye A, Czobor P, Dessoubrais C, Macher JP. Suicide attempts and family history of suicide in three psychiatric populations. Suicide Life Threat Behav. 2005 Dec;35(6):702-13 |
| Staner L, Ertlé S, Boeijinga P, Rinaudo G, Arnal MA, Muzet A, Luthringer R. Next-day residual effects of hypnotics in DSM-IV primary insomnia: a driving simulator study with simultaneous electroencephalogram monitoring. Psychopharmacology (Berl). 2005 Oct;181(4):790-8. |
| Hodé Y, Reimold M, Demazières A, Reischl G, Bayle F, Nuss P, Hameg A, Dib M, Macher JP. A positron emission tomography (PET) study of cerebral dopamine D2 and serotonine 5-HT2A receptor occupancy in patients treated with cyamemazine (Tercian). Psychopharmacology (Berl). 2005 Jul;180(2):377-84. |
| Haba-Rubio J, Staner L, Petiau C, Erb G, Schunck T, Macher JP. Restless legs syndrome and low brain iron levels in patients with haemochromatosis. J Neurol Neurosurg Psychiatry. 2005 Jul;76(7):1009-10. |
| Le Bon O, Chabanski S, Dramaix M, Staner L, Pelc I, Linkowski P. Inverse association between Slow Wave Activity per cycle and the number of ultradian sleep cycles per night in healthy humans. Clin Neurophysiol. 2005 Jul;116(7):1493-500. |
| Prise en charge d’un état dépressif chez un patient adulte hospitalisé / MACHER JP, DUVAL F, GAUBERT S, COLLECTIF. In SYNAPSE, 06/2005, n° 216. – pp 39-60. |
| Exploration de la fonction dopaminergique dans les dépressions bipolaires et unipolaires / MONREAL JA, DUVAL F, MOKRANI MC, PINAULT G, MACHER JP. In ANNALES MEDICO-PSYCHOLOGIQUES, 06/2005, n° 5. – pp 399-404. |
| Haba-Rubio J, Staner L, Krieger J, Macher JP. Periodic limb movements and sleepiness in obstructive sleep apnea patients. Sleep Med. 2005 May;6(3):225-9. |
| Prise en charge des schizophrènes en hospitalisation / MACHER JP, DUVAL F, HODE Y. In PARIS : SYNAPSE, 04/2005, n° 214. – pp 41-53. |
| Chalon S, Pereira A, Lainey E, Vandenhende F, Watkin JG, Staner L, Granier LA. Comparative effects of duloxetine and desipramine on sleep EEG in healthy subjects. Psychopharmacology (Berl). 2005 Feb;177(4):357-65. |
| Duval F, Mokrani MC, Ortiz JA, Schulz P, Champeval C, Macher JP. Neuroendocrine predictors of the evolution of depression. Dialogues Clin Neurosci. 2005;7(3):273-82. |
| Staner L. Sleep disturbances, psychiatric disorders, and psychotropic drugs. Dialogues Clin Neurosci. 2005;7(4):323-34. |
| Duval F, Crocq MA, Guillon MS, Mokrani MC, Monreal J, Bailey P, Macher JP. Increased adrenocorticotropin suppression after dexamethasone administration in sexually abused adolescents with posttraumatic stress disorder. Ann N Y Acad Sci. 2004 Dec;1032:273-5. |
| Haba-Rubio J, Staner L, Krieger J, Macher JP. What is the clinical significance of periodic limb movements during sleep?. Neurophysiol Clin. 2004 Dec;34(6):293-300. |
| Duval F, Crocq MA, Guillon MS, Mokrani MC, Monreal J, Bailey P, Macher JP. Increased adrenocorticotropin suppression following dexamethasone administration in sexually abused adolescents with posttraumatic stress disorder. Psychoneuroendocrinology. 2004 Nov;29(10):1281-9. |
| Bolo NR, Hodé Y, Macher JP. Long-term sequestration of fluorinated compounds in tissues after fluvoxamine or fluoxetine treatment: a fluorine magnetic resonance spectroscopy study in vivo. MAGMA. 2004 May;16(6):268-76. |
| Macher JP, Luthringer R, Staner L. Spectral EEG sleep profiles as a tool for prediction of clinical response to antidepressant treatment. Dialogues Clin Neurosci. 2004 Mar;6(1):78-81. |
| Staner L, Cornette F, Maurice D, Viardot G, Le Bon O, Haba J, Staner C, Luthringer R, Muzet A, Macher JP. Sleep microstructure around sleep onset differentiates major depressive insomnia from primary insomnia. J Sleep Res. 2003 Dec;12(4):319-30. |
| Staner L, Luthringer R, Macher JP. [Development of compounds active in insomnia: recent developments and methodological aspects]. Rev Neurol (Paris). 2003 Nov;159(11 Suppl):6S48-55. |
| Schunck T, Erb G, Gilles C, Hode Y, Namer IJ, Fuder H, Luthringer R. fMRI in anxiety. Dialogues Clin Neurosci. 2003 Sep;5(3):246-7. |
| Staner L. Sleep and anxiety disorders. Dialogues Clin Neurosci. 2003 Sep;5(3):249-58. |
| Haba-Rubio J, Staner L, Cornette F, Lainey E, Luthringer R, Krieger J, Macher JP. Acute low single dose of apomorphine reduces periodic limb movements but has no significant effect on sleep arousals: a preliminary report. Neurophysiol Clin. 2003 Sep;33(4):180-4. |
| Le Bon O, Murphy JR, Staner L, Hoffmann G, Kormoss N, Kentos M, Dupont P, Lion K, Pelc I, Verbanck P. Double-blind, placebo-controlled study of the efficacy of trazodone in alcohol post-withdrawal syndrome: polysomnographic and clinical evaluations. J Clin Psychopharmacol. 2003 Aug;23(4):377-83. |
| Duval F, Mokrani MC, Monreal J, Bailey P, Valdebenito M, Crocq MA, Macher JP. Dopamine and serotonin function in untreated schizophrenia: clinical correlates of the apomorphine and d-fenfluramine tests. Psychoneuroendocrinology. 2003 Jul;28(5):627-42. |
| Boeijinga PH, Nedelec JF, Demazières A, Souan ML, Gamand S, Gilles C, Parot P, Staner L, Luthringer R, Macher JP. Characterization of the CNS effects of naftidrofuryl (Praxilène) by quantitative EEG and functional MRI: a study in healthy elderly subjects. Neuropsychobiology. 2003;48(3):160-8. |
| Endocrinologie et psychiatrie / DUVAL F. In EMC Psychiatrie, 03/2003, n° 37-640-A-10. – n° 113. |
| Staner L, Duval F, Haba J, Mokrani MC, Macher JP. Disturbances in hypothalamo pituitary adrenal and thyroid axis identify different sleep EEG patterns in major depressed patients. J Psychiatr Res. 2003 Jan-Feb;37(1):1-8. |
| Gilles C, Schunck T, Erb G, Namer IJ, Hodé Y, Nedelec JF, Boeijinga P, Luthringer R, Mâcher JP. Human models as tools in the development of psychotropic drugs. Dialogues Clin Neurosci. 2002 Dec;4(4):377-87. |
| Duval F, Mokrani MC, Monreal J, Weiss T, Fattah S, Hamel B, Macher JP. Interaction between the serotonergic system and HPA and HPT axes in patients with major depression: implications for pathogenesis of suicidal behavior. Dialogues Clin Neurosci. 2002 Dec;4(4):417. |
| Staner L. Sleep-wake mechanisms and drug discovery: sleep EEG as a tool for the development of CNS-acting drugs. Dialogues Clin Neurosci. 2002 Dec;4(4):342-50. |
| Fossion P, Ledoux Y, Valente F, Servais L, Staner L, Pelc I, Minner P. Psychiatric disorders and social characteristics among second-generation Moroccan migrants in Belgium: an age-and gender-controlled study conducted in a psychiatric emergency department. Eur Psychiatry. 2002 Dec;17(8):443-50. |
| Haba-Rubio J, Staner L, Macher JP. Periodic arousals or periodic limb movements during sleep?. Sleep Med. 2002 Nov;3(6):517-20. |
| Staner L, Uyanik G, Correa H, Tremeau F, Monreal J, Crocq MA, Stefos G, Morris-Rosendahl DJ, Macher JP. A dimensional impulsive-aggressive phenotype is associated with the A218C polymorphism of the tryptophan hydroxylase gene: a pilot study in well-characterized impulsive inpatients. Am J Med Genet. 2002 Jul 8;114(5):553-7. |
| Corrêa H, Duval F, Mokrani MC, Bailey P, Trémeau F, Staner L, Diep TS, Crocq MA, Macher JP. Serotonergic function and suicidal behavior in schizophrenia. Schizophr Res. 2002 Jul 1;56(1-2):75-85. |
| Le Bon O, Staner L, Rivelli SK, Hoffmann G, Pelc I, Linkowski P. Correlations using the NREM-REM sleep cycle frequency support distinct regulation mechanisms for REM and NREM sleep. J Appl Physiol (1985). 2002 Jul;93(1):141-6. |
| Coatanhay A, Soufflet L, Staner L, Boeijinga P. EEG source identification: frequency analysis during sleep. C R Biol. 2002 Apr;325(4):273-82. |
| Massat I, Souery D, Del-Favero J, Van Gestel S, Serretti A, Macciardi F, Smeraldi E, Kaneva R, Adolfsson R, Nylander PO, Blackwood D, Muir W, Papadimitriou GN, Dikeos D, Oruc L, Segman RH, Ivezic S, Aschauer H, Ackenheil M, Fuchshuber S, Dam H, Jakovljevic M, Peltonen L, Hilger C, Hentges F, Staner L, Milanova V, Jazin E, Lerer B, Van Broeckhoven C, Mendlewicz J. Positive association of dopamine D2 receptor polymorphism with bipolar affective disorder in a European Multicenter Association Study of affective disorders. Am J Med Genet. 2002 Mar 8;114(2):177-85. |
| Le Bon O, Staner L, Hoffmann G, Kentos M, Pelc I, Linkowski P. Shorter REM latency associated with more sleep cycles of a shorter duration in healthy humans. Psychiatry Res. 2001 Oct 10;104(1):75-83. |
| Monreal JA, Staner L. [Mania, parkinson disease and risperidone Case report]. Actas Esp Psiquiatr. 2001 Sep-Oct;29(5):349-50. |
| Staner L, Linker T, Toussaint M, Danjou P, Roegel JC, Luthringer R, Le Fur G, Macher JP. Effects of the selective activation of 5-HT3 receptors on sleep: a polysomnographic study in healthy volunteers. Eur Neuropsychopharmacol. 2001 Aug;11(4):301-5. |
| Duval F, Mokrani MC, Correa H, Bailey P, Valdebenito M, Monreal J, Crocq MA, Macher JP. Lack of effect of HPA axis hyperactivity on hormonal responses to d-fenfluramine in major depressed patients: implications for pathogenesis of suicidal behaviour. Psychoneuroendocrinology. 2001 Jul;26(5):521-37. |
| Trémeau F, Staner L, Duval F, Bailey P, Crocq MA, Corrêa H, Dessoubrais C, Macher JP. Suicidal behavior in schizophrenia and family history of suicide. Dialogues Clin Neurosci. 2001 Jun;3(2):120-1. |
| Le Bon O, Staner L, Hoffmann G, Dramaix M, San Sebastian I, Murphy JR, Kentos M, Pelc I, Linkowski P. The first-night effect may last more than one night. J Psychiatr Res. 2001 May-Jun;35(3):165-72. |
| Corrêa H, Duval F, Claude MM, Bailey P, Tremeau F, Diep TS, Crocq MA, Castro JO, Macher JP. Noradrenergic dysfunction and antidepressant treatment response. Eur Neuropsychopharmacol. 2001 Apr;11(2):163-8. |
| Staner L, Duval F, Calvi-Gries F, Mokrani MC, Bailey P, Hode Y, Toussaint M, Luthringer R, Muzet A, Macher JP. Morning and evening TSH response to TRH and sleep EEG disturbances in major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2001 Apr;25(3):535-47. |
| Bolo NR, Hodé Y, Nédélec JF, Lainé E, Wagner G, Macher JP. Brain pharmacokinetics and tissue distribution in vivo of fluvoxamine and fluoxetine by fluorine magnetic resonance spectroscopy. Neuropsychopharmacology. 2000 Oct;23(4):428-38. |
| Mokrani M, Duval F, Diep TS, Bailey PE, Macher JP. Multihormonal responses to clonidine in patients with affective and psychotic symptoms. Psychoneuroendocrinology. 2000 Oct;25(7):741-52. |
| Duval F, Mokrani MC, Bailey P, Corrêa H, Crocq MA, Son Diep T, Macher JP. Serotonergic and noradrenergic function in depression: clinical correlates. Dialogues Clin Neurosci. 2000 Sep;2(3):299-308. |
| Le Bon O, Hoffmann G, Tecco J, Staner L, Noseda A, Pelc I, Linkowski P. Mild to moderate sleep respiratory events: one negative night may not be enough. Chest. 2000 Aug;118(2):353-9. |
| Blairy S, Massat I, Staner L, Le Bon O, Van Gestel S, Van Broeckhoven C, Hilger C, Hentges F, Souery D, Mendlewicz J. 5-HT2a receptor polymorphism gene in bipolar disorder and harm avoidance personality trait. Am J Med Genet. 2000 Jun 12;96(3):360-4. |
| Corrêa H, Duval F, Mokrani M, Bailey P, Trémeau F, Staner L, Diep TS, Hodé Y, Crocq MA, Macher JP. Prolactin response to D-fenfluramine and suicidal behavior in depressed patients. Psychiatry Res. 2000 Apr 10;93(3):189-99. |
| Massat I, Souery D, Lipp O, Blairy S, Papadimitriou G, Dikeos D, Ackenheil M, Fuchshuber S, Hilger C, Kaneva R, Milanova V, Verheyen G, Raeymaekers P, Staner L, Oruc L, Jakovljevic M, Serretti A, Macciardi F, Van Broeckhoven C, Mendlewicz J. A European multicenter association study of HTR2A receptor polymorphism in bipolar affective disorder. Am J Med Genet. 2000 Apr 3;96(2):136-40. |
| Toussaint M, Luthringer R, Staner L, Muzet A, Macher J. Changes in EEG power density during sleep laboratory adaptation in depressed inpatients. Biol Psychiatry. 2000 Apr 1;47(7):626-33. |
| Duval F, Mokrani MC, Crocq MA, Bailey PE, Diep TS, Correa H, Macher JP. Dopaminergic function and the cortisol response to dexamethasone in psychotic depression. Prog Neuropsychopharmacol Biol Psychiatry. 2000 Feb;24(2):207-25. |
| Duval F, Mokrani MC, Bailey P, Correa H, Diep TS, Crocq MA, Macher JP. Thyroid axis activity and serotonin function in major depressive episode. Psychoneuroendocrinology. 1999 Oct;24(7):695-712. |
| Duval F. This is a comprehensive review of biological abnormalites observed in bipolar/unipolar mood disorder We do not ignore that conflicting results may be found in the literature, but attempted, nevertheless, to summarize the currents trends. Dialogues Clin Neurosci. 1999 Jun;1(1):22-3. |
| Stefos G, Staner L, Kerkhofs M, Hubain P, Mendlewicz J, Linkowski P. Shortened REM latency as a psychobiological marker for psychotic depression? An age-, gender-, and polarity-controlled study. Biol Psychiatry. 1998 Dec 15;44(12):1314-20. |
| Staner L, Moulart D, Mendlewicz J. [Multicenter trials in the treatment of depression: some methodological issues]. Encephale. 1998 Nov-Dec;24(6):522-9. |
| Staner L, Mendlewicz J. [Heredity and role of serotonin in aggressive impulsive behavior]. Encephale. 1998 Jul-Aug;24(4):355-64. |
| Fossion P, Staner L, Dramaix M, Kempenaers C, Kerkhofs M, Hubain P, Verbanck P, Mendlewicz J, Linkowski P. Does sleep EEG data distinguish between UP, BPI or BPII major depressions? An age and gender controlled study. J Affect Disord. 1998 Jun;49(3):181-7. |
| Bauwens F, Pardoen D, Staner L, Dramaix M, Mendlewicz J. Social adjustment and the course of affective illness: a one-year controlled longitudinal study involving bipolar and unipolar outpatients. Depress Anxiety. 1998;8(2):50-7. |
| Morris-Rosendahl DJ, Burgert E, Uyanik G, Mayerova A, Duval F, Macher JP, Crocq MA. Analysis of the CAG repeats in the SCA1 and B37 genes in schizophrenic and bipolar I disorder patients: tentative association between B37 and schizophrenia. Am J Med Genet. 1997 May 31;74(3):324-30. |
| Mokrani MC, Duval F, Crocq MA, Bailey P, Macher JP. HPA axis dysfunction in depression: correlation with monoamine system abnormalities. Psychoneuroendocrinology. 1997;22 Suppl 1:S63-8. |
| Duval F, Mokrani MC, Crocq MA, Jautz M, Bailey P, Diep TS, Macher JP. Effect of antidepressant medication on morning and evening thyroid function tests during a major depressive episode. Arch Gen Psychiatry. 1996 Sep;53(9):833-40. |
| Valdivieso S, Duval F, Mokrani MC, Schaltenbrand N, Castro JO, Crocq MA, Macher JP. Growth hormone response to clonidine and the cortisol response to dexamethasone in depressive patients. Psychiatry Res. 1996 Feb 28;60(1):23-32. |
| Griffon N, Crocq MA, Pilon C, Martres MP, Mayerova A, Uyanik G, Burgert E, Duval F, Macher JP, Javoy-Agid F, Tamminga CA, Schwartz JC, Sokoloff P. Dopamine D3 receptor gene: organization, transcript variants, and polymorphism associated with schizophrenia. Am J Med Genet. 1996 Feb 16;67(1):63-70. |
Mokrani MC, Duval F, Crocq MA, Bailey PE, Macher JP. Multihormonal responses to apomorphine in mental illness. Psychoneuroendocrinology. 1995;20(4):365-75.
| Duval F, Mokrani MC, Crocq MA, Bailey P, Macher JP. Influence of thyroid hormones on morning and evening TSH response to TRH in major depression. Biol Psychiatry. 1994 Jun 15;35(12):926-34. |
| Bailey P, Duval F, Macher JP. Treating negative symptoms. Br J Psychiatry. 1994 May;164(5):699-700. |
| Duval F, Mokrani MC, Macher JP, Crocq MA, Castro JO, Bailey P, Lataste X. Neuroendocrine profile of SDZ HDC-912 and OPC-4392, two new atypical antipsychotic drugs, in schizophrenic patients. Psychopharmacology (Berl). 1993;110(1-2):177-80. |
| Crocq MA, Mant R, Asherson P, Williams J, Hode Y, Mayerova A, Collier D, Lannfelt L, Sokoloff P, Schwartz JC. Association between schizophrenia and homozygosity at the dopamine D3 receptor gene. J Med Genet. 1992 Dec;29(12):858-60. |
| Crocq MA, Macher JP, Duval F. [Unipolar-bipolar distinction The genetic arguments]. Encephale. 1992 Jan;18 Spec No 1:31-4. |
| Macher JP, Crocq MA, Duval F, Minot R, Rogue P, Koehl C, Hirth C, Gindein J, Fleck F. Bio-clinical prevalence or non-prevalence of drug addiction over psychiatric symptomatology. Med Law. 1992;11(1-2):11-8. |
| Duval F, Mokrani MC, Oliveira Castro J, Crocq MA, Andrade EE, Macher JP. Circadian effects on the TSH response to TRH in depressed patients. Clin Neuropharmacol. 1992;15 Suppl 1 Pt A:384A-385A. |
Macher JP, Minot R, Duval F, Luthringer R, Toussaint M, Schaltenbrand N. [Neuro-electrophysiologic studies in abstinent and depressed alcoholic patients treated with tianeptine]. Presse Med. 1991 Nov 14;20(37):1853-7.
| Rosenberg S, Weber N, Crocq MA, Duval F, Macher JP. Random number generation by normal, alcoholic and schizophrenic subjects. Psychol Med. 1990 Nov;20(4):953-60. |
| Duval F, Macher JP, Mokrani MC. Difference between evening and morning thyrotropin responses to protirelin in major depressive episode. Arch Gen Psychiatry. 1990 May;47(5):443-8 |
Macher JP, Crocq MA, Duval F, Minot R, Toussaint M. [Non-invasive or minor invasive methods of diagnosis and therapeutic follow-up in psychiatry]. Ann Med Psychol (Paris). 1988 Jun;146(6):584-7.
Macher JP, Fornari P, Crocq MA, Duval F, Hassler MC, Rebourg C, Fleig C. [Nosographic divergences and semeiologic convergences A unified approach within the framework of a protocol of psychologico-clinical and biological exploration]. Ann Med Psychol (Paris). 1984 Jul-Aug;142(7):1011-6.
| Trémeau F, Malaspina D, Duval F, Correa H, Hager-Budny M, Coin-Bariou L, Macher JP, Gorman J. Facial expressiveness in patients with schizophrenia, as compared to depressed patients and nonpatient controls. Am J Psychiatry 2005;162:92-101 |
| Trémeau F, Staner L, Duval F, Corrêa H, Crocq MA, Darreye A, Czobor P, Dessoubrais C, Macher JP. Suicide attempts and family history of suicide in three psychiatric populations. Suicide Life Threat Behav. 2005 Dec;35(6):702-13 |
| Staner L, Ertlé S, Boeijinga P, Rinaudo G, Arnal MA, Muzet A, Luthringer R. Next-day residual effects of hypnotics in DSM-IV primary insomnia: a driving simulator study with simultaneous electroencephalogram monitoring. Psychopharmacology (Berl). 2005 Oct;181(4):790-8. |
| Hodé Y, Reimold M, Demazières A, Reischl G, Bayle F, Nuss P, Hameg A, Dib M, Macher JP. A positron emission tomography (PET) study of cerebral dopamine D2 and serotonine 5-HT2A receptor occupancy in patients treated with cyamemazine (Tercian). Psychopharmacology (Berl). 2005 Jul;180(2):377-84. |
| Haba-Rubio J, Staner L, Petiau C, Erb G, Schunck T, Macher JP. Restless legs syndrome and low brain iron levels in patients with haemochromatosis. J Neurol Neurosurg Psychiatry. 2005 Jul;76(7):1009-10. |
| Le Bon O, Chabanski S, Dramaix M, Staner L, Pelc I, Linkowski P. Inverse association between Slow Wave Activity per cycle and the number of ultradian sleep cycles per night in healthy humans. Clin Neurophysiol. 2005 Jul;116(7):1493-500. |
| Prise en charge d’un état dépressif chez un patient adulte hospitalisé / MACHER JP, DUVAL F, GAUBERT S, COLLECTIF. In SYNAPSE, 06/2005, n° 216. – pp 39-60. |
| Exploration de la fonction dopaminergique dans les dépressions bipolaires et unipolaires / MONREAL JA, DUVAL F, MOKRANI MC, PINAULT G, MACHER JP. In ANNALES MEDICO-PSYCHOLOGIQUES, 06/2005, n° 5. – pp 399-404. |
| Haba-Rubio J, Staner L, Krieger J, Macher JP. Periodic limb movements and sleepiness in obstructive sleep apnea patients. Sleep Med. 2005 May;6(3):225-9. |
| Prise en charge des schizophrènes en hospitalisation / MACHER JP, DUVAL F, HODE Y. In PARIS : SYNAPSE, 04/2005, n° 214. – pp 41-53. |
| Chalon S, Pereira A, Lainey E, Vandenhende F, Watkin JG, Staner L, Granier LA. Comparative effects of duloxetine and desipramine on sleep EEG in healthy subjects. Psychopharmacology (Berl). 2005 Feb;177(4):357-65. |
| Duval F, Mokrani MC, Ortiz JA, Schulz P, Champeval C, Macher JP. Neuroendocrine predictors of the evolution of depression. Dialogues Clin Neurosci. 2005;7(3):273-82. |
| Staner L. Sleep disturbances, psychiatric disorders, and psychotropic drugs. Dialogues Clin Neurosci. 2005;7(4):323-34. |
| Duval F, Crocq MA, Guillon MS, Mokrani MC, Monreal J, Bailey P, Macher JP. Increased adrenocorticotropin suppression after dexamethasone administration in sexually abused adolescents with posttraumatic stress disorder. Ann N Y Acad Sci. 2004 Dec;1032:273-5. |
| Haba-Rubio J, Staner L, Krieger J, Macher JP. What is the clinical significance of periodic limb movements during sleep?. Neurophysiol Clin. 2004 Dec;34(6):293-300. |
| Duval F, Crocq MA, Guillon MS, Mokrani MC, Monreal J, Bailey P, Macher JP. Increased adrenocorticotropin suppression following dexamethasone administration in sexually abused adolescents with posttraumatic stress disorder. Psychoneuroendocrinology. 2004 Nov;29(10):1281-9. |
| Bolo NR, Hodé Y, Macher JP. Long-term sequestration of fluorinated compounds in tissues after fluvoxamine or fluoxetine treatment: a fluorine magnetic resonance spectroscopy study in vivo. MAGMA. 2004 May;16(6):268-76. |
| Macher JP, Luthringer R, Staner L. Spectral EEG sleep profiles as a tool for prediction of clinical response to antidepressant treatment. Dialogues Clin Neurosci. 2004 Mar;6(1):78-81. |
| Staner L, Cornette F, Maurice D, Viardot G, Le Bon O, Haba J, Staner C, Luthringer R, Muzet A, Macher JP. Sleep microstructure around sleep onset differentiates major depressive insomnia from primary insomnia. J Sleep Res. 2003 Dec;12(4):319-30. |
| Staner L, Luthringer R, Macher JP. [Development of compounds active in insomnia: recent developments and methodological aspects]. Rev Neurol (Paris). 2003 Nov;159(11 Suppl):6S48-55. |
| Schunck T, Erb G, Gilles C, Hode Y, Namer IJ, Fuder H, Luthringer R. fMRI in anxiety. Dialogues Clin Neurosci. 2003 Sep;5(3):246-7. |
| Staner L. Sleep and anxiety disorders. Dialogues Clin Neurosci. 2003 Sep;5(3):249-58. |
| Haba-Rubio J, Staner L, Cornette F, Lainey E, Luthringer R, Krieger J, Macher JP. Acute low single dose of apomorphine reduces periodic limb movements but has no significant effect on sleep arousals: a preliminary report. Neurophysiol Clin. 2003 Sep;33(4):180-4. |
| Le Bon O, Murphy JR, Staner L, Hoffmann G, Kormoss N, Kentos M, Dupont P, Lion K, Pelc I, Verbanck P. Double-blind, placebo-controlled study of the efficacy of trazodone in alcohol post-withdrawal syndrome: polysomnographic and clinical evaluations. J Clin Psychopharmacol. 2003 Aug;23(4):377-83. |
| Duval F, Mokrani MC, Monreal J, Bailey P, Valdebenito M, Crocq MA, Macher JP. Dopamine and serotonin function in untreated schizophrenia: clinical correlates of the apomorphine and d-fenfluramine tests. Psychoneuroendocrinology. 2003 Jul;28(5):627-42. |
| Boeijinga PH, Nedelec JF, Demazières A, Souan ML, Gamand S, Gilles C, Parot P, Staner L, Luthringer R, Macher JP. Characterization of the CNS effects of naftidrofuryl (Praxilène) by quantitative EEG and functional MRI: a study in healthy elderly subjects. Neuropsychobiology. 2003;48(3):160-8. |
| Endocrinologie et psychiatrie / DUVAL F. In EMC Psychiatrie, 03/2003, n° 37-640-A-10. – n° 113. |
| Staner L, Duval F, Haba J, Mokrani MC, Macher JP. Disturbances in hypothalamo pituitary adrenal and thyroid axis identify different sleep EEG patterns in major depressed patients. J Psychiatr Res. 2003 Jan-Feb;37(1):1-8. |
| Gilles C, Schunck T, Erb G, Namer IJ, Hodé Y, Nedelec JF, Boeijinga P, Luthringer R, Mâcher JP. Human models as tools in the development of psychotropic drugs. Dialogues Clin Neurosci. 2002 Dec;4(4):377-87. |
| Duval F, Mokrani MC, Monreal J, Weiss T, Fattah S, Hamel B, Macher JP. Interaction between the serotonergic system and HPA and HPT axes in patients with major depression: implications for pathogenesis of suicidal behavior. Dialogues Clin Neurosci. 2002 Dec;4(4):417. |
| Staner L. Sleep-wake mechanisms and drug discovery: sleep EEG as a tool for the development of CNS-acting drugs. Dialogues Clin Neurosci. 2002 Dec;4(4):342-50. |
| Fossion P, Ledoux Y, Valente F, Servais L, Staner L, Pelc I, Minner P. Psychiatric disorders and social characteristics among second-generation Moroccan migrants in Belgium: an age-and gender-controlled study conducted in a psychiatric emergency department. Eur Psychiatry. 2002 Dec;17(8):443-50. |
| Haba-Rubio J, Staner L, Macher JP. Periodic arousals or periodic limb movements during sleep?. Sleep Med. 2002 Nov;3(6):517-20. |
| Staner L, Uyanik G, Correa H, Tremeau F, Monreal J, Crocq MA, Stefos G, Morris-Rosendahl DJ, Macher JP. A dimensional impulsive-aggressive phenotype is associated with the A218C polymorphism of the tryptophan hydroxylase gene: a pilot study in well-characterized impulsive inpatients. Am J Med Genet. 2002 Jul 8;114(5):553-7. |
| Corrêa H, Duval F, Mokrani MC, Bailey P, Trémeau F, Staner L, Diep TS, Crocq MA, Macher JP. Serotonergic function and suicidal behavior in schizophrenia. Schizophr Res. 2002 Jul 1;56(1-2):75-85. |
| Le Bon O, Staner L, Rivelli SK, Hoffmann G, Pelc I, Linkowski P. Correlations using the NREM-REM sleep cycle frequency support distinct regulation mechanisms for REM and NREM sleep. J Appl Physiol (1985). 2002 Jul;93(1):141-6. |
| Coatanhay A, Soufflet L, Staner L, Boeijinga P. EEG source identification: frequency analysis during sleep. C R Biol. 2002 Apr;325(4):273-82. |
| Massat I, Souery D, Del-Favero J, Van Gestel S, Serretti A, Macciardi F, Smeraldi E, Kaneva R, Adolfsson R, Nylander PO, Blackwood D, Muir W, Papadimitriou GN, Dikeos D, Oruc L, Segman RH, Ivezic S, Aschauer H, Ackenheil M, Fuchshuber S, Dam H, Jakovljevic M, Peltonen L, Hilger C, Hentges F, Staner L, Milanova V, Jazin E, Lerer B, Van Broeckhoven C, Mendlewicz J. Positive association of dopamine D2 receptor polymorphism with bipolar affective disorder in a European Multicenter Association Study of affective disorders. Am J Med Genet. 2002 Mar 8;114(2):177-85. |
| Le Bon O, Staner L, Hoffmann G, Kentos M, Pelc I, Linkowski P. Shorter REM latency associated with more sleep cycles of a shorter duration in healthy humans. Psychiatry Res. 2001 Oct 10;104(1):75-83. |
| Monreal JA, Staner L. [Mania, parkinson disease and risperidone Case report]. Actas Esp Psiquiatr. 2001 Sep-Oct;29(5):349-50. |
| Staner L, Linker T, Toussaint M, Danjou P, Roegel JC, Luthringer R, Le Fur G, Macher JP. Effects of the selective activation of 5-HT3 receptors on sleep: a polysomnographic study in healthy volunteers. Eur Neuropsychopharmacol. 2001 Aug;11(4):301-5. |
| Duval F, Mokrani MC, Correa H, Bailey P, Valdebenito M, Monreal J, Crocq MA, Macher JP. Lack of effect of HPA axis hyperactivity on hormonal responses to d-fenfluramine in major depressed patients: implications for pathogenesis of suicidal behaviour. Psychoneuroendocrinology. 2001 Jul;26(5):521-37. |
| Trémeau F, Staner L, Duval F, Bailey P, Crocq MA, Corrêa H, Dessoubrais C, Macher JP. Suicidal behavior in schizophrenia and family history of suicide. Dialogues Clin Neurosci. 2001 Jun;3(2):120-1. |
| Le Bon O, Staner L, Hoffmann G, Dramaix M, San Sebastian I, Murphy JR, Kentos M, Pelc I, Linkowski P. The first-night effect may last more than one night. J Psychiatr Res. 2001 May-Jun;35(3):165-72. |
| Corrêa H, Duval F, Claude MM, Bailey P, Tremeau F, Diep TS, Crocq MA, Castro JO, Macher JP. Noradrenergic dysfunction and antidepressant treatment response. Eur Neuropsychopharmacol. 2001 Apr;11(2):163-8. |
| Staner L, Duval F, Calvi-Gries F, Mokrani MC, Bailey P, Hode Y, Toussaint M, Luthringer R, Muzet A, Macher JP. Morning and evening TSH response to TRH and sleep EEG disturbances in major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2001 Apr;25(3):535-47. |
| Bolo NR, Hodé Y, Nédélec JF, Lainé E, Wagner G, Macher JP. Brain pharmacokinetics and tissue distribution in vivo of fluvoxamine and fluoxetine by fluorine magnetic resonance spectroscopy. Neuropsychopharmacology. 2000 Oct;23(4):428-38. |
| Mokrani M, Duval F, Diep TS, Bailey PE, Macher JP. Multihormonal responses to clonidine in patients with affective and psychotic symptoms. Psychoneuroendocrinology. 2000 Oct;25(7):741-52. |
| Duval F, Mokrani MC, Bailey P, Corrêa H, Crocq MA, Son Diep T, Macher JP. Serotonergic and noradrenergic function in depression: clinical correlates. Dialogues Clin Neurosci. 2000 Sep;2(3):299-308. |
| Le Bon O, Hoffmann G, Tecco J, Staner L, Noseda A, Pelc I, Linkowski P. Mild to moderate sleep respiratory events: one negative night may not be enough. Chest. 2000 Aug;118(2):353-9. |
| Blairy S, Massat I, Staner L, Le Bon O, Van Gestel S, Van Broeckhoven C, Hilger C, Hentges F, Souery D, Mendlewicz J. 5-HT2a receptor polymorphism gene in bipolar disorder and harm avoidance personality trait. Am J Med Genet. 2000 Jun 12;96(3):360-4. |
| Corrêa H, Duval F, Mokrani M, Bailey P, Trémeau F, Staner L, Diep TS, Hodé Y, Crocq MA, Macher JP. Prolactin response to D-fenfluramine and suicidal behavior in depressed patients. Psychiatry Res. 2000 Apr 10;93(3):189-99. |
| Massat I, Souery D, Lipp O, Blairy S, Papadimitriou G, Dikeos D, Ackenheil M, Fuchshuber S, Hilger C, Kaneva R, Milanova V, Verheyen G, Raeymaekers P, Staner L, Oruc L, Jakovljevic M, Serretti A, Macciardi F, Van Broeckhoven C, Mendlewicz J. A European multicenter association study of HTR2A receptor polymorphism in bipolar affective disorder. Am J Med Genet. 2000 Apr 3;96(2):136-40. |
| Toussaint M, Luthringer R, Staner L, Muzet A, Macher J. Changes in EEG power density during sleep laboratory adaptation in depressed inpatients. Biol Psychiatry. 2000 Apr 1;47(7):626-33. |
| Duval F, Mokrani MC, Crocq MA, Bailey PE, Diep TS, Correa H, Macher JP. Dopaminergic function and the cortisol response to dexamethasone in psychotic depression. Prog Neuropsychopharmacol Biol Psychiatry. 2000 Feb;24(2):207-25. |
| Duval F, Mokrani MC, Bailey P, Correa H, Diep TS, Crocq MA, Macher JP. Thyroid axis activity and serotonin function in major depressive episode. Psychoneuroendocrinology. 1999 Oct;24(7):695-712. |
| Duval F. This is a comprehensive review of biological abnormalites observed in bipolar/unipolar mood disorder We do not ignore that conflicting results may be found in the literature, but attempted, nevertheless, to summarize the currents trends. Dialogues Clin Neurosci. 1999 Jun;1(1):22-3. |
| Stefos G, Staner L, Kerkhofs M, Hubain P, Mendlewicz J, Linkowski P. Shortened REM latency as a psychobiological marker for psychotic depression? An age-, gender-, and polarity-controlled study. Biol Psychiatry. 1998 Dec 15;44(12):1314-20. |
| Staner L, Moulart D, Mendlewicz J. [Multicenter trials in the treatment of depression: some methodological issues]. Encephale. 1998 Nov-Dec;24(6):522-9. |
| Staner L, Mendlewicz J. [Heredity and role of serotonin in aggressive impulsive behavior]. Encephale. 1998 Jul-Aug;24(4):355-64. |
| Fossion P, Staner L, Dramaix M, Kempenaers C, Kerkhofs M, Hubain P, Verbanck P, Mendlewicz J, Linkowski P. Does sleep EEG data distinguish between UP, BPI or BPII major depressions? An age and gender controlled study. J Affect Disord. 1998 Jun;49(3):181-7. |
| Bauwens F, Pardoen D, Staner L, Dramaix M, Mendlewicz J. Social adjustment and the course of affective illness: a one-year controlled longitudinal study involving bipolar and unipolar outpatients. Depress Anxiety. 1998;8(2):50-7. |
| Morris-Rosendahl DJ, Burgert E, Uyanik G, Mayerova A, Duval F, Macher JP, Crocq MA. Analysis of the CAG repeats in the SCA1 and B37 genes in schizophrenic and bipolar I disorder patients: tentative association between B37 and schizophrenia. Am J Med Genet. 1997 May 31;74(3):324-30. |
| Mokrani MC, Duval F, Crocq MA, Bailey P, Macher JP. HPA axis dysfunction in depression: correlation with monoamine system abnormalities. Psychoneuroendocrinology. 1997;22 Suppl 1:S63-8. |
| Duval F, Mokrani MC, Crocq MA, Jautz M, Bailey P, Diep TS, Macher JP. Effect of antidepressant medication on morning and evening thyroid function tests during a major depressive episode. Arch Gen Psychiatry. 1996 Sep;53(9):833-40. |
| Valdivieso S, Duval F, Mokrani MC, Schaltenbrand N, Castro JO, Crocq MA, Macher JP. Growth hormone response to clonidine and the cortisol response to dexamethasone in depressive patients. Psychiatry Res. 1996 Feb 28;60(1):23-32. |
| Griffon N, Crocq MA, Pilon C, Martres MP, Mayerova A, Uyanik G, Burgert E, Duval F, Macher JP, Javoy-Agid F, Tamminga CA, Schwartz JC, Sokoloff P. Dopamine D3 receptor gene: organization, transcript variants, and polymorphism associated with schizophrenia. Am J Med Genet. 1996 Feb 16;67(1):63-70. |
Mokrani MC, Duval F, Crocq MA, Bailey PE, Macher JP. Multihormonal responses to apomorphine in mental illness. Psychoneuroendocrinology. 1995;20(4):365-75.
| Duval F, Mokrani MC, Crocq MA, Bailey P, Macher JP. Influence of thyroid hormones on morning and evening TSH response to TRH in major depression. Biol Psychiatry. 1994 Jun 15;35(12):926-34. |
| Bailey P, Duval F, Macher JP. Treating negative symptoms. Br J Psychiatry. 1994 May;164(5):699-700. |
| Duval F, Mokrani MC, Macher JP, Crocq MA, Castro JO, Bailey P, Lataste X. Neuroendocrine profile of SDZ HDC-912 and OPC-4392, two new atypical antipsychotic drugs, in schizophrenic patients. Psychopharmacology (Berl). 1993;110(1-2):177-80. |
| Crocq MA, Mant R, Asherson P, Williams J, Hode Y, Mayerova A, Collier D, Lannfelt L, Sokoloff P, Schwartz JC. Association between schizophrenia and homozygosity at the dopamine D3 receptor gene. J Med Genet. 1992 Dec;29(12):858-60. |
| Crocq MA, Macher JP, Duval F. [Unipolar-bipolar distinction The genetic arguments]. Encephale. 1992 Jan;18 Spec No 1:31-4. |
| Macher JP, Crocq MA, Duval F, Minot R, Rogue P, Koehl C, Hirth C, Gindein J, Fleck F. Bio-clinical prevalence or non-prevalence of drug addiction over psychiatric symptomatology. Med Law. 1992;11(1-2):11-8. |
| Duval F, Mokrani MC, Oliveira Castro J, Crocq MA, Andrade EE, Macher JP. Circadian effects on the TSH response to TRH in depressed patients. Clin Neuropharmacol. 1992;15 Suppl 1 Pt A:384A-385A. |
Macher JP, Minot R, Duval F, Luthringer R, Toussaint M, Schaltenbrand N. [Neuro-electrophysiologic studies in abstinent and depressed alcoholic patients treated with tianeptine]. Presse Med. 1991 Nov 14;20(37):1853-7.
| Rosenberg S, Weber N, Crocq MA, Duval F, Macher JP. Random number generation by normal, alcoholic and schizophrenic subjects. Psychol Med. 1990 Nov;20(4):953-60. |
| Duval F, Macher JP, Mokrani MC. Difference between evening and morning thyrotropin responses to protirelin in major depressive episode. Arch Gen Psychiatry. 1990 May;47(5):443-8 |
Macher JP, Crocq MA, Duval F, Minot R, Toussaint M. [Non-invasive or minor invasive methods of diagnosis and therapeutic follow-up in psychiatry]. Ann Med Psychol (Paris). 1988 Jun;146(6):584-7.
Macher JP, Fornari P, Crocq MA, Duval F, Hassler MC, Rebourg C, Fleig C. [Nosographic divergences and semeiologic convergences A unified approach within the framework of a protocol of psychologico-clinical and biological exploration]. Ann Med Psychol (Paris). 1984 Jul-Aug;142(7):1011-6.
